Literature DB >> 10535477

Case report: Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C.

S Miyano1, H Togashi, H Shinzawa, K Sugahara, T Matsuo, Y Takeda, K Saito, T Saito, S Ishiyama, M Kaneko, T Takahashi.   

Abstract

A 67-year-old man with hepatitis C virus infection and histological features of chronic active hepatitis was treated with human recombinant interferon alpha-2b. He responded successfully to interferon with normalization of serum alanine aminotransferase and continuous eradication of hepatitis C virus. However, 4.5 years after the end of interferon therapy, hepatocellular carcinoma, 20 mm in diameter, was detected by routine ultrasonographic screening. The patient underwent surgical treatment for resection of the hepatocellular carcinoma. The non-cancerous liver tissue was histologically normal. This suggests that patients who have shown a complete response to interferon therapy for chronic hepatitis C should be followed up closely.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535477     DOI: 10.1046/j.1440-1746.1999.01954.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

Review 1.  Chemoprevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis.

Authors:  Gianni Testino; Paolo Borro
Journal:  World J Hepatol       Date:  2013-10-27

2.  Development of a hepatocellular carcinoma in a chronic hepatitis C patient 18 years after achieving a sustained virological response to interferon therapy: case report and literature review.

Authors:  Masaya Saito; Yasushi Seo; Yoshihiko Yano; Akira Miki; Yukiko Morinaga; Tomoo Itoh; Masaru Yoshida; Takeshi Azuma
Journal:  Clin J Gastroenterol       Date:  2012-02-18

3.  Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C.

Authors:  Atsushi Tanaka; Satoko Uegaki; Hiroko Kurihara; Kiyoshi Aida; Masaki Mikami; Ikuo Nagashima; Junji Shiga; Hajime Takikawa
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

4.  Development of hepatocellular carcinoma in patients with chronic hepatitis C more than 10 years after sustained virological response to interferon therapy.

Authors:  Keiichiro Nojiri; Kazushi Sugimoto; Katsuya Shiraki; Satoko Kusagawa; Junichiro Tanaka; Tetsuya Beppu; Norihiko Yamamoto; Yoshiyuki Takei; Akira Hashimoto; Atsuya Shimizu; Shigeru Omori; Masahiko Tameda; Koujiro Takase
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

5.  Remote development of hepatocellular carcinoma in patients with liver cirrhosis type B serologically cured for HBs antigenemia with long-standing normalization of ALT values.

Authors:  Shogo Okoshi; Masato Igarashi; Takeshi Suda; Hiroshi Iwamatsu; Kohji Watanabe; Kiyoshi Ishihara; Norio Ogata; Minoru Nomoto; Toru Takahashi; Takafumi Ichida; Hitoshi Asakura; Koei Nihei; Isao Kurosaki
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

6.  Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin.

Authors:  Roland El Braks; Nathalie Ganne-Carrie; Helene Fontaine; Jacques Paries; Veronique Grando-Lemaire; Michel Beaugrand; Stanislas Pol; Jean-Claude Trinchet
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

7.  HEPATOCELLULAR CARCINOMA IN A NON-CIRRHOTIC PATIENT WITH SUSTAINED VIROLOGICAL RESPONSE AFTER HEPATITIS C TREATMENT.

Authors:  Angelo Alves de Mattos; Patrícia dos Santos Marcon; Fernanda Schild Branco de Araújo; Gabriela Perdomo Coral; Cristiane Valle Tovo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-12       Impact factor: 1.846

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.